Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2024 Filed Apr 24, 2024 23:41 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 28,369 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-24-013345 · form4.xml · derivative · entry 4 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,369 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 23:41 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 28,369 | $161.49 | $4,581,184.99 |
DisclosureSEC source: 0001127602-24-013345 · form4.xml · nonDerivative · entry 2 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,507.0786 F2 · price: Weighted average price of the shares sold. The price range was $161.4202 to $161.575. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 23:41 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionCommon Stock | 28,369 | $80.29 | $2,277,747.01 |
DisclosureSEC source: 0001127602-24-013345 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,876.0786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 12:35 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 855 | $158.50 | $135,517.50 |
DisclosureSEC source: 0001127602-24-013248 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 4,003.5522 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 15:49 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009934 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,304.6191 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 15:50 UTC |
Biggs M. BrettDirector
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009935 · form4.xml · nonDerivative · entry 1 Biggs M. Brett · CIK 0001662848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,879.7318 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 15:52 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009936 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,464.3174 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 15:55 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009937 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,507.7973 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 15:57 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009938 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,384.2812 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 15:58 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 193 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009939 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,327.4979 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 15:59 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 171 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009940 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,823.8943 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 16:01 UTC |
McEvoy AshleyDirector
|
GrantCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009941 · form4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,409.4819 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 16:02 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 47 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009942 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,735.3921 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 16:03 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009943 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,371.6558 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 17:25 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 776 | $158.11 | $122,693.36 |
DisclosureSEC source: 0001127602-24-008411 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 4,858.5522 F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units(RSU's) settled in common stock. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:08 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,323 | $0.00 Strike: $78.52 | $0.00 |
DisclosureSEC source: 0001127602-24-006824 · form4.xml · derivative · entry 6 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,323 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:08 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 20,323 | $161.00 | $3,272,003.00 |
DisclosureSEC source: 0001127602-24-006824 · form4.xml · nonDerivative · entry 3 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 978.8547 Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:08 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 20,323 | $78.52 | $1,595,761.96 |
DisclosureSEC source: 0001127602-24-006824 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,301.8547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units(RSU's) settled in common stock. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:09 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-24-006827 · form4.xml · derivative · entry 5 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,388 Underlying: Common Stock · 22,000 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:09 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 22,000 | $161.32 | $3,549,103.80 |
DisclosureSEC source: 0001127602-24-006827 · form4.xml · nonDerivative · entry 2 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,845.2471 F1 · price: Weighted average price of the shares sold. The price range was $161.31 to $161.39. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:09 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionCommon Stock | 22,000 | $80.29 | $1,766,380.00 |
DisclosureSEC source: 0001127602-24-006827 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,845.2471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,865 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-24-006828 · form4.xml · derivative · entry 5 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,865 Underlying: Common Stock · 3,865 shares Expires 2030-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 3,865 | $160.60 | $620,719.00 |
DisclosureSEC source: 0001127602-24-006828 · form4.xml · nonDerivative · entry 2 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,885.7527 Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
Exercise / conversionCommon Stock | 3,865 | $139.24 | $538,162.60 |
DisclosureSEC source: 0001127602-24-006828 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,750.7527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units(RSU's) settled in common stock. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:08 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
OtherCommon Stock | 6,255.4006 | $159.47 | $997,522.46 |
DisclosureSEC source: 0001127602-24-006824 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse, By Retirement Plan Trustees Disclosed balance after: 2,615.5239 Read SEC document |
| February 21, 2024 Filed Feb 22, 2024 21:19 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,430 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-24-006301 · form4.xml · derivative · entry 8 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,859 Underlying: Common Stock · 31,430 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 22, 2024 21:19 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 31,430 | $159.90 | $5,025,767.01 |
DisclosureSEC source: 0001127602-24-006301 · form4.xml · nonDerivative · entry 2 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,681.1747 F2 · price: Weighted average price of the shares sold. The price range was $159.90 to $159.92. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 21, 2024 Filed Feb 22, 2024 21:19 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionCommon Stock | 31,430 | $91.07 | $2,862,330.10 |
DisclosureSEC source: 0001127602-24-006301 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,111.1747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units(RSU's) settled in common stock. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:16 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-24-006295 · form4.xml · derivative · entry 7 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,388 Underlying: Common Stock · 22,000 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:16 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 22,000 | $158.98 | $3,497,450.00 |
DisclosureSEC source: 0001127602-24-006295 · form4.xml · nonDerivative · entry 2 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,845.2471 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:16 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionCommon Stock | 22,000 | $80.29 | $1,766,380.00 |
DisclosureSEC source: 0001127602-24-006295 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,845.2471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes shares acquired through the issuer's dividend reinvestment plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 15, 2024 Filed Feb 22, 2024 21:16 UTC |
Coombe Gary ACEO - Grooming
|
GrantRestricted Stock Units · Derivative | 40.9469 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006295 · form4.xml · derivative · entry 6 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 771.4918 Underlying: Common Stock · 40.9469 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Feb 22, 2024 21:19 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 26.0366 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006301 · form4.xml · derivative · entry 7 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380.5722 Underlying: Common Stock · 26.0366 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Feb 26, 2024 21:08 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantRestricted Stock Units · Derivative | 37.047 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006824 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507.8394 Underlying: Common Stock · 37.047 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F3 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F3 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Feb 26, 2024 21:11 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 3.0797 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006828 · form4.xml · derivative · entry 4 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.8608 Underlying: Common Stock · 3.0797 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Mar 5, 2024 17:25 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 46.326 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008411 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 736.6535 Underlying: Common Stock · 46.326 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Apr 24, 2024 23:41 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 2.1724 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013345 · form4.xml · derivative · entry 5 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.5772 Underlying: Common Stock · 2.1724 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed May 1, 2024 17:08 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 26.0366 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013725 · form4.xml · derivative · entry 7 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406.6088 Underlying: Common Stock · 26.0366 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed May 17, 2024 19:20 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantRestricted Stock Units · Derivative | 8.1203 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015803 · form4.xml · derivative · entry 5 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45.4133 Underlying: Common Stock · 8.1203 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed May 21, 2024 12:42 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 14.9322 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016053 · form4.xml · derivative · entry 4 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100.101 Underlying: Common Stock · 14.9322 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Aug 5, 2024 21:41 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantRestricted Stock Units · Derivative | 170.7955 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021656 · form4.xml · derivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,476.6257 Underlying: Common Stock · 170.7955 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Aug 5, 2024 21:49 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 192.2432 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021672 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,489.8654 Underlying: Common Stock · 192.2432 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Aug 5, 2024 21:51 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantRestricted Stock Units · Derivative | 16.8058 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021676 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101.9852 Underlying: Common Stock · 16.8058 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2024 Filed Aug 5, 2024 21:52 UTC |
Schulten AndreChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 13.6223 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021678 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74.0956 Underlying: Common Stock · 13.6223 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 18:00 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $78.52 | $0.00 |
DisclosureSEC source: 0001127602-24-003638 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,323 Underlying: Common Stock · 25,000 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 18:00 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 25,000 | $159.00 | $3,975,000.00 |
DisclosureSEC source: 0001127602-24-003638 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973.189 F1 · price: Weighted average price of the shares sold. The price range was $159.00 to $159.015. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 18:00 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 25,000 | $78.52 | $1,963,000.00 |
DisclosureSEC source: 0001127602-24-003638 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,973.189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 13:37 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $78.52 | $0.00 |
DisclosureSEC source: 0001127602-24-002537 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,323 Underlying: Common Stock · 45,000 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 13:37 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 45,000 | $156.00 | $7,020,000.00 |
DisclosureSEC source: 0001127602-24-002537 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973.189 Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 13:37 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 45,000 | $78.52 | $3,533,400.00 |
DisclosureSEC source: 0001127602-24-002537 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,973.189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.